Ansell (OTCMKTS:ANSLF – Get Free Report) is one of 81 public companies in the “Medical Instruments & Supplies” industry, but how does it weigh in compared to its rivals? We will compare Ansell to related businesses based on the strength of its institutional ownership, earnings, profitability, valuation, dividends, analyst recommendations and risk.
This table compares Ansell and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Institutional and Insider Ownership
39.0% of Ansell shares are held by institutional investors. Comparatively, 48.3% of shares of all “Medical Instruments & Supplies” companies are held by institutional investors. 22.1% of shares of all “Medical Instruments & Supplies” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Earnings & Valuation
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Ansell Competitors||$1.44 billion||$176.50 million||385.50|
Ansell’s rivals have higher revenue and earnings than Ansell. Ansell is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
This is a summary of current ratings for Ansell and its rivals, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
As a group, “Medical Instruments & Supplies” companies have a potential upside of 23.01%. Given Ansell’s rivals higher possible upside, analysts plainly believe Ansell has less favorable growth aspects than its rivals.
Ansell pays an annual dividend of $0.40 per share and has a dividend yield of 2.7%. Ansell pays out 130.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. As a group, “Medical Instruments & Supplies” companies pay a dividend yield of 2.1% and pay out 33.9% of their earnings in the form of a dividend.
Ansell rivals beat Ansell on 8 of the 10 factors compared.
Ansell Company Profile
Ansell Limited designs, develops, and manufactures protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates in two segments, Healthcare and Industrial. The Healthcare segment manufactures and markets solutions comprising surgical gloves, single use and examination gloves, and clean and sterile gloves and garments, as well as consumables used by hospitals, surgical centers, dental practices, veterinary clinics, first responders, manufacturers, auto repair shops, chemical plants, laboratories, and life sciences and pharmaceutical companies. The Industrial segment manufactures and markets hand and chemical protective clothing solutions for a range of industrial applications, including automotive, chemical, metal fabrication, machinery and equipment, food, construction, mining, oil and gas, utilities, logistics, and first responders. The company was formerly known as Pacific Dunlop Limited and changed its name to Ansell Limited in 2002. Ansell Limited was founded in 1893 and is based in Richmond, Australia.
Receive News & Ratings for Ansell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ansell and related companies with MarketBeat.com's FREE daily email newsletter.